BIOTECH BELGIUM: what changed
BIOTECH BELGIUM
Largest movements
- Receivables within one year +€18,995
up €18,995 (+113%), from €16,798 to €35,793
of which Other amounts receivable: +€17,275
- Stocks and contracts -€10,000
down €10,000 (-97.9%), from €10,219 to €219
- Cash -€2,931
down €2,931 (-32.4%), from €9,052 to €6,122
mainly Receivables within one year (-€18,995)
- Profit (loss) carried forward +€1,913
up €1,913 (+23.6%), from €8,104 to €10,017
- Advances received +€1,797
new in 2025: €1,797
- Tax, wage and social debts +€1,752
up €1,752 (+81.2%), from €2,158 to €3,910
- Trade debts +€602
up €602 (+15.8%), from €3,807 to €4,409
- Write-downs +€25,432
new in 2025: €25,432
- Gross operating margin +€23,898
up €23,898 (+440%), from €5,431 to €29,328
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €36,069 | €42,133 | +€6,064 | +16.8% |
| Current assets | 29/58 | €36,069 | €42,133 | +€6,064 | +16.8% |
| Stocks and contracts in progress | 3 | €10,219 | €219 | -€10,000 | -97.9% |
| Stocks | 30/36 | €10,219 | €219 | -€10,000 | -97.9% |
| Amounts receivable within one year | 40/41 | €16,798 | €35,793 | +€18,995 | +113% |
| Trade receivables | 40 | €4,232 | €5,952 | +€1,720 | +40.6% |
| Other amounts receivable | 41 | €12,566 | €29,841 | +€17,275 | +137% |
| Cash at bank and in hand | 54/58 | €9,052 | €6,122 | -€2,931 | -32.4% |
| Total equity and liabilities | 10/49 | €36,069 | €42,133 | +€6,064 | +16.8% |
| Equity | 10/15 | €30,104 | €32,017 | +€1,913 | +6.4% |
| Contributions | 10/11 | €22,000 | €22,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,104 | €10,017 | +€1,913 | +23.6% |
| Amounts payable | 17/49 | €5,965 | €10,116 | +€4,151 | +69.6% |
| Amounts payable within one year | 42/48 | €5,965 | €10,116 | +€4,151 | +69.6% |
| Trade debts | 44 | €3,807 | €4,409 | +€602 | +15.8% |
| Suppliers | 440/4 | €3,807 | €4,409 | +€602 | +15.8% |
| Advances received on contracts in progress | 46 | - | €1,797 | +€1,797 | |
| Taxes, remuneration and social security | 45 | €2,158 | €3,910 | +€1,752 | +81.2% |
| Taxes | 450/3 | €2,158 | €3,910 | +€1,752 | +81.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €25,432 | +€25,432 | |
| Other operating charges | 640/8 | €618 | €400 | -€218 | -35.3% |
| Gross operating margin | 9900 | €5,431 | €29,328 | +€23,898 | +440% |
| Operating profit (loss) | 9901 | €4,813 | €3,497 | -€1,316 | -27.3% |
| Financial income | 75/76B | €8 | €14 | +€6 | +74.0% |
| Recurring financial income | 75 | €8 | €14 | +€6 | +74.0% |
| Financial charges | 65/66B | €101 | €141 | +€40 | +40.1% |
| Recurring financial charges | 65 | €101 | €141 | +€40 | +40.1% |
| Profit (loss) for the period before taxes | 9903 | €4,720 | €3,370 | -€1,350 | -28.6% |
| Income taxes | 67/77 | €1,663 | €1,457 | -€206 | -12.4% |
| Profit (loss) for the period | 9904 | €3,057 | €1,913 | -€1,144 | -37.4% |
| Profit (loss) for the period to be appropriated | 9905 | €3,057 | €1,913 | -€1,144 | -37.4% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.